Search PubMed⌕ Search

PubMed · 6476544

External defibrillation: new technologies.

Abstract

Recent technological advances have enhanced our ability to diagnose and treat ventricular fibrillation (VF). Self-adhesive electrode pads for external defibrillation are as effective as standard hand-held paddle electrodes, and have substantial advantages for monitoring during transportation and in the emergency department/intensive care unit/critical care unit. These electrode pads work equally well whether placed in apex-anterior or apex-posterior positions. Preapplication in calm, prearrest circumstances assures accurate placement and enhances shock success. Transthoracic impedance is a critical determinant of the success of low-energy shocks. Prediction of transthoracic impedance in advance of the first shock is now feasible. First-shock energy can then be based on impedance, and inappropriate low energies for high-impedance patients may be avoided. Automatic external defibrillation by minimally trained rescuers extends our ability to treat out-of-hospital ventricular fibrillation. A vertical defibrillation pathway, using the tongue as one electrode site, allows rapid, automated detection of VF. Animal defibrillation studies and preliminary human studies (during elective cardioversion) have demonstrated the efficacy of the pathway and defined the impedance and energy requirements. Clinical trials of the device for out-of-hospital defibrillation are now in progress.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R E Kerber. 1984. External defibrillation: new technologies.. https://doi.org/10.1016/s0196-0644(84)80440-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Bioelectricity.

Explore the source record for details and available documents.

Cardiography, Impedance↗

Bioimpedance to prevent heart failure hospitalization.

Transthoracic and whole-body bioimpedance monitoring has been commercially available for years; however, attention to its use as a diagnostic and event-monitoring modality has not been routinely applied in patients with heart failure (HF). In 2005, intrathoracic bioimpedance monitoring via an implantable cardioverter defibrillator brought new awareness of bioimpedance technology. In addition, new knowledge about congestion in HF, including length of time a patient is congested before seeking emergency care, lack of sensitivity of common signs and symptoms used to monitor congestion and diagnose HF exacerbation, and poor clinical outcomes when hypervolemia is present, heightened the need for more aggressive assessment and management. Bioimpedance device monitoring provides data needed to make treatment decisions that promote euvolemia and optimal cardiac performance. This review summarizes three options for measurement of bioimpedance hemodynamic data, discusses its use in preventing HF hospitalization, and describes issues that need to be overcome before bioimpedance monitoring can be routinely used in HF management.

Cardiography, Impedance↗

Fetuses with congenital heart disease demonstrate signs of decreased cerebral impedance.

OBJECTIVE: The purpose of this study was to determine whether fetuses with a congenital heart defect demonstrate changes in cerebrovascular impedance. STUDY DESIGN: Fetal echocardiograms from January 2001 to May 2005 were reviewed. Cases had sonographically diagnosed congenital heart defects; control subjects were gestational age-matched fetuses with normal echocardiograms. The pulsatility index in the middle cerebral artery was used to measure impedance to cerebral blood flow. Abnormal middle cerebral artery pulsatility index was defined as less than the 5th percentile. Cases were subgrouped into mixing versus nonmixing lesions. RESULTS: Of 142 total fetuses, there were significantly more abnormal middle cerebral artery pulsatility indices in the cases (5/71) than in the control subjects (0/71; P = .023); all abnormal middle cerebral artery pulsatility indices occurred in the fetuses with admixing cardiac lesions. CONCLUSION: Fetuses with congenital heart defect are significantly more likely to have decreased cerebrovascular impedance. This may represent a marker of cerebral hypoxemia that is due to intracardiac mixing of oxygenated and deoxygenated blood. Theoretically, this hypoxemia may contribute to the cause of abnormal neurologic development in these infants.

Cardiography, Impedance↗